https://pharmadog.xyz/news/156789 pharmadog en 2026-07-29T04:57:00.000Z Biotech earnings season kicks off as Agios reports Phase 2 setback for sickle-cell drug https://pharmadog.xyz/news/155785 pharmadog en 2026-07-28T23:34:07.000Z ADA faces member backlash and calls for CEO and CSO resignations after expert expulsions https://pharmadog.xyz/news/155358 pharmadog en 2026-07-28T21:15:04.000Z Webinar: Building the Intelligence Engine for Drug Discovery R&D Teams https://pharmadog.xyz/news/155054 pharmadog en 2026-07-28T19:29:57.000Z Six key issues we’re watching at Fauci’s hearing https://pharmadog.xyz/news/155010 pharmadog en 2026-07-28T19:08:10.000Z FDA reminds investors about the risks of advisory panels https://pharmadog.xyz/news/154794 pharmadog en 2026-07-28T18:33:11.000Z J&J proposes $5.5B talc settlement https://pharmadog.xyz/news/154795 pharmadog en 2026-07-28T18:08:40.000Z FDA offers updated guidance for generics of weight loss blockbusters https://pharmadog.xyz/news/154583 pharmadog en 2026-07-28T17:00:20.000Z Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn https://pharmadog.xyz/news/154584 pharmadog en 2026-07-28T16:37:26.000Z STAT+: Bracing for another Fauci hearing https://pharmadog.xyz/news/154426 pharmadog en 2026-07-28T16:02:00.000Z GSK prepares for patent cliff with $2.5B cost-cutting plan https://pharmadog.xyz/news/154245 pharmadog en 2026-07-28T15:17:47.000Z Oak Hill Bio merges with RA Capital SPAC; InnoCare's TYK2 drug hits in Phase 3 https://pharmadog.xyz/news/154246 pharmadog en 2026-07-28T15:05:10.000Z FDA staff say Replimune's melanoma trial failed to prove RP1 works https://pharmadog.xyz/news/154170 pharmadog en 2026-07-28T14:27:07.000Z GSK shares rise as $2.5B cost-cutting plan unveiled https://pharmadog.xyz/news/154146 pharmadog en 2026-07-28T14:24:45.000Z The future of gray-market peptides https://pharmadog.xyz/news/154082 pharmadog en 2026-07-28T14:11:41.000Z STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials https://pharmadog.xyz/news/154038 pharmadog en 2026-07-28T14:00:04.000Z Alnylam's stock is down 30% despite a booming biotech market. Here's why https://pharmadog.xyz/news/154083 pharmadog en 2026-07-28T13:39:53.000Z STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment https://pharmadog.xyz/news/154084 pharmadog en 2026-07-28T13:25:49.000Z STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more https://pharmadog.xyz/news/154085 pharmadog en 2026-07-28T13:22:35.000Z STAT+: Three questions with Whoop’s new CMO https://pharmadog.xyz/news/154039 pharmadog en 2026-07-28T13:15:35.000Z Mirae raises $5.4M to turn patient texts into data for doctors https://pharmadog.xyz/news/154062 pharmadog en 2026-07-28T13:13:18.000Z FDA says Replimune’s melanoma data package is ‘not interpretable,’ setting up tough adcomm https://pharmadog.xyz/news/156404 pharmadog en 2026-07-28T13:07:00.000Z DSV A/S manager files share transaction report https://pharmadog.xyz/news/154985 pharmadog en 2026-07-28T13:02:00.000Z Eli Lilly tops new biopharma ranking on launch success, development speed https://pharmadog.xyz/news/153846 pharmadog en 2026-07-28T12:54:07.000Z Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study https://pharmadog.xyz/news/153714 pharmadog en 2026-07-28T12:00:02.000Z Claris collects $118M to take eye drop into pivotal testing next year https://pharmadog.xyz/news/153778 pharmadog en 2026-07-28T12:00:00.000Z The FDA was all in on AI. Will that change? https://pharmadog.xyz/news/153779 pharmadog en 2026-07-28T12:00:00.000Z An eye drug biotech banks $118M and stocks its executive suite https://pharmadog.xyz/news/153758 pharmadog en 2026-07-28T11:57:15.000Z Anthony Fauci’s pandemic-era diary entries https://pharmadog.xyz/news/153715 pharmadog en 2026-07-28T11:35:41.000Z Updated: GSK reveals three-year blueprint to cut costs and propel R&D https://pharmadog.xyz/news/153621 pharmadog en 2026-07-28T11:12:55.000Z Apnimed eyes up to $160M IPO to prep for sleep apnea drug launch https://pharmadog.xyz/news/153622 pharmadog en 2026-07-28T11:06:13.000Z Oak Hill takes SPAC track to Nasdaq with Roche asset in tow https://pharmadog.xyz/news/153498 pharmadog en 2026-07-28T11:00:10.000Z Updated: Altimmune’s GLP-1-based shot cuts drinking in patients with alcoholism https://pharmadog.xyz/news/156405 pharmadog en 2026-07-28T11:00:00.000Z OKYO Pharma CSO Raj Patil boosts stake to 20,030 shares https://pharmadog.xyz/news/154220 pharmadog en 2026-07-28T10:33:00.000Z Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options https://pharmadog.xyz/news/154121 pharmadog en 2026-07-28T10:31:00.000Z Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win https://pharmadog.xyz/news/153434 pharmadog en 2026-07-28T10:00:00.000Z STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment https://pharmadog.xyz/news/154122 pharmadog en 2026-07-28T09:52:00.000Z GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard https://pharmadog.xyz/news/154123 pharmadog en 2026-07-28T09:09:00.000Z Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial https://pharmadog.xyz/news/154777 pharmadog en 2026-07-28T09:04:00.000Z Acrosian debuts as AI-focused biometrics CRO https://pharmadog.xyz/news/154013 pharmadog en 2026-07-28T08:55:00.000Z Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video https://pharmadog.xyz/news/153267 pharmadog en 2026-07-28T08:30:00.000Z STAT+: CMS evaluates one year of health tech progress, announces eight new pledge categories https://pharmadog.xyz/news/153268 pharmadog en 2026-07-28T08:30:00.000Z STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD https://pharmadog.xyz/news/153269 pharmadog en 2026-07-28T08:30:00.000Z Opinion: STAT+: Dementia finally has a business model https://pharmadog.xyz/news/153270 pharmadog en 2026-07-28T08:30:00.000Z After PCOS became PMOS, there’s hope for new awareness among Black and Latina women https://pharmadog.xyz/news/156407 pharmadog en 2026-07-28T08:00:00.000Z Danske Bank reports senior staff transactions on July 28, 2026 https://pharmadog.xyz/news/156406 pharmadog en 2026-07-28T08:00:00.000Z Danske Bank reports share sell-off by APMH Invest under ongoing buy-back program https://pharmadog.xyz/news/153798 pharmadog en 2026-07-28T07:24:00.000Z GSK partner Hansoh reports another phase 3 win for priority ADC https://pharmadog.xyz/news/152658 pharmadog en 2026-07-28T04:36:00.000Z As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk https://pharmadog.xyz/news/153797 pharmadog en 2026-07-28T02:17:00.000Z Boston Scientific unveils major restructuring, plots job cuts amid savings drive https://pharmadog.xyz/news/156336 pharmadog en 2026-07-28T00:00:00.000Z Industry urges FDA to clarify and broaden QSP guidance for first-in-human dose selection https://pharmadog.xyz/news/156335 pharmadog en 2026-07-28T00:00:00.000Z FDA draft guidance seeks clearer, more flexible QSP dose selection for first-in-human trials https://pharmadog.xyz/news/156337 pharmadog en 2026-07-28T00:00:00.000Z WHO publishes first interim list of 12 medical device regulators eligible for WHO-listed authority status https://pharmadog.xyz/news/151382 pharmadog en 2026-07-27T20:45:59.000Z STAT+: HIV resurgence is feared as global funding to combat the disease falls 18% https://pharmadog.xyz/news/150906 pharmadog en 2026-07-27T18:39:32.000Z Virginia federal judge says FDA should reconsider mifepristone restrictions https://pharmadog.xyz/news/150907 pharmadog en 2026-07-27T18:30:58.000Z The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says https://pharmadog.xyz/news/150842 pharmadog en 2026-07-27T18:13:14.000Z STAT+: Pharma’s drug spending deflection https://pharmadog.xyz/news/153799 pharmadog en 2026-07-27T17:48:00.000Z ‘This could be a large market’: Novo Holdings-backed Claris secures $118M for corneal disease drug https://pharmadog.xyz/news/150798 pharmadog en 2026-07-27T17:40:36.000Z Capricor's DMD therapy lacks efficacy, FDA says ahead of adcomm https://pharmadog.xyz/news/150671 pharmadog en 2026-07-27T17:21:05.000Z Six wellness peptides win backing from FDA advisory committee https://pharmadog.xyz/news/150538 pharmadog en 2026-07-27T16:12:00.000Z MapLight dives despite positive data for schizophrenia drug https://pharmadog.xyz/news/150539 pharmadog en 2026-07-27T15:46:00.000Z Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug https://pharmadog.xyz/news/150474 pharmadog en 2026-07-27T15:40:29.000Z Yarrow to begin trading as it targets Graves; FDA approves Otsuka's ADHD pill https://pharmadog.xyz/news/150498 pharmadog en 2026-07-27T15:40:18.000Z UPDATE: FDA disputes Capricor's claims of Phase 3 success for DMD cell therapy https://pharmadog.xyz/news/150499 pharmadog en 2026-07-27T15:27:47.000Z MapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout https://pharmadog.xyz/news/150381 pharmadog en 2026-07-27T15:24:00.000Z Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail https://pharmadog.xyz/news/150475 pharmadog en 2026-07-27T15:17:42.000Z MapLight’s schizophrenia drug dampens once-daily hopes despite Phase 2 win https://pharmadog.xyz/news/150357 pharmadog en 2026-07-27T15:17:42.000Z MapLight’s schizophrenia drug disappoints once-daily hopes despite Phase 2 win https://pharmadog.xyz/news/150540 pharmadog en 2026-07-27T15:00:00.000Z FDA scientists question Capricor data; Legend CEO steps down https://pharmadog.xyz/news/150282 pharmadog en 2026-07-27T14:20:39.000Z Sarepta names former AbbVie R&D exec Michael Severino as next CEO https://pharmadog.xyz/news/150541 pharmadog en 2026-07-27T14:16:00.000Z Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO https://pharmadog.xyz/news/151097 pharmadog en 2026-07-27T13:56:00.000Z RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC https://pharmadog.xyz/news/150194 pharmadog en 2026-07-27T13:49:21.000Z STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive https://pharmadog.xyz/news/150150 pharmadog en 2026-07-27T13:38:43.000Z Legend CEO Ying Huang resigns; Carvykti chief named interim leader https://pharmadog.xyz/news/150195 pharmadog en 2026-07-27T13:19:47.000Z STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more https://pharmadog.xyz/news/150086 pharmadog en 2026-07-27T13:08:23.000Z STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug https://pharmadog.xyz/news/156408 pharmadog en 2026-07-27T13:00:00.000Z Vaisala senior manager Vesa Pylvänäinen disposes 1,582 shares at €56.92 each https://pharmadog.xyz/news/156409 pharmadog en 2026-07-27T13:00:00.000Z Vaisala executive Vesa Pylvänäinen sells 1,582 shares at €56.92 each https://pharmadog.xyz/news/150066 pharmadog en 2026-07-27T12:59:15.000Z AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure https://pharmadog.xyz/news/150067 pharmadog en 2026-07-27T12:54:08.000Z Otsuka’s ADHD approval opens up new drug class with $615M opportunity https://pharmadog.xyz/news/149925 pharmadog en 2026-07-27T12:30:43.000Z Sarepta turns to Michael Severino as CEO, looking to move past recent turmoil https://pharmadog.xyz/news/149949 pharmadog en 2026-07-27T12:23:54.000Z Argenx deepens immuno expertise with $2.2B Forte Biosciences buy https://pharmadog.xyz/news/149870 pharmadog en 2026-07-27T12:13:35.000Z A trend that isn’t fading, ultra-processed baby foods https://pharmadog.xyz/news/149871 pharmadog en 2026-07-27T12:00:00.000Z STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease https://pharmadog.xyz/news/106257 pharmadog en 2026-07-27T12:00:00.000Z [Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services https://pharmadog.xyz/news/80789 pharmadog en 2026-07-27T12:00:00.000Z [Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus https://pharmadog.xyz/news/149826 pharmadog en 2026-07-27T11:08:17.000Z AstraZeneca looks to AI to ease risk in late-stage trials, speed up filings https://pharmadog.xyz/news/149718 pharmadog en 2026-07-27T11:03:08.000Z Updated: AstraZeneca foresees blockbuster sales for Claudin 18.2 ADC, but Ultomiris flops in rare disease https://pharmadog.xyz/news/149719 pharmadog en 2026-07-27T11:00:49.000Z Schrödinger debuts AI agent Bunsen to use its physics software https://pharmadog.xyz/news/150450 pharmadog en 2026-07-27T10:54:00.000Z Apnimed aspires for up to $160M IPO as sleep apnea pill launch nears https://pharmadog.xyz/news/149720 pharmadog en 2026-07-27T10:46:03.000Z Argenx to pick up autoimmune biotech Forte Biosciences for $2.2B https://pharmadog.xyz/news/150449 pharmadog en 2026-07-27T10:35:00.000Z MapLight shares sink on mixed phase 2 schizophrenia readout https://pharmadog.xyz/news/150332 pharmadog en 2026-07-27T10:31:00.000Z FDA approves Freenome colorectal cancer blood test to be marketed by Abbott https://pharmadog.xyz/news/150333 pharmadog en 2026-07-27T10:10:00.000Z InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test https://pharmadog.xyz/news/150233 pharmadog en 2026-07-27T10:05:00.000Z After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration https://pharmadog.xyz/news/156411 pharmadog en 2026-07-27T10:00:00.000Z Nokia Oyj - Johtohenkilöiden liiketoimet (Hammarén) https://pharmadog.xyz/news/156412 pharmadog en 2026-07-27T10:00:00.000Z Nokia Corporation - Managers' transactions (Mahajan) https://pharmadog.xyz/news/156413 pharmadog en 2026-07-27T10:00:00.000Z Nokia Oyj - Johtohenkilöiden liiketoimet (Mahajan) https://pharmadog.xyz/news/156410 pharmadog en 2026-07-27T10:00:00.000Z Nokia Corporation - Managers' transactions (Hammarén) https://pharmadog.xyz/news/156414 pharmadog en 2026-07-27T10:00:00.000Z Nokia board member Timo Ihamuotila purchases 33,700 shares at around €8.45 each https://pharmadog.xyz/news/156415 pharmadog en 2026-07-27T10:00:00.000Z Nokia board member Timo Ihamuotila reports share purchases across multiple markets on July 24, 2026 https://pharmadog.xyz/news/150234 pharmadog en 2026-07-27T09:35:00.000Z Legend Biotech CEO abruptly steps down without permanent replacement https://pharmadog.xyz/news/149566 pharmadog en 2026-07-27T09:00:00.000Z From confidence to capital: Positioning biotech for the next growth cycle https://pharmadog.xyz/news/156416 pharmadog en 2026-07-27T08:59:00.000Z Danske Bank A/S, transactions by persons discharging managerial responsibilities https://pharmadog.xyz/news/156417 pharmadog en 2026-07-27T08:59:00.000Z Danske Bank A/S, ledende medarbejderes transaktioner https://pharmadog.xyz/news/149440 pharmadog en 2026-07-27T08:30:00.000Z Opinion: How midwives like me can help fight medical misinformation https://pharmadog.xyz/news/149438 pharmadog en 2026-07-27T08:30:00.000Z Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency https://pharmadog.xyz/news/149439 pharmadog en 2026-07-27T08:30:00.000Z STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities https://pharmadog.xyz/news/149330 pharmadog en 2026-07-27T07:26:21.000Z STAT+: Argenx to buy Forte Biosciences for $2.2B